OXTR and Anxiety: Similarly, chronic high-dose i.c.v OXT administration (over 14 days) produced an anxiety-like behavioral phenotype and reduced the expression of OXTR levels, whereas chronic low-dose OXT prevented hyper anxiety and reduced ACTH sensitivity and adrenal hypertrophy [100].